NASDAQ · Medical - Devices

Holdco Nuvo Group D.G Ltd. Ordinary Shares (NUVO) Stock

$0.17 +100.00% NASDAQ: NUVO Healthcare

Holdco Nuvo Group D.G Ltd specializes in the innovation, development, and commercialization of medical devices designed for monitoring pregnancies. Its operations span Israel, the United States, and international markets.

Valuation

MetricValue
Price$0.17
Market Cap$5.65M
P/E Ratio-0.10
P/B Ratio-0.05
P/S Ratio32.13
EPS (TTM)$-1.64
52-Week High$0.22
52-Week Low$0.17
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-36.55%
ROA-104.03%
ROCE-1700.00%
Gross Margin-8.52%
Operating Margin
Net Margin
Debt/Equity-0.17
Current Ratio0.05

Annual Financials (USD)

Metric20192020202120222023
Revenue$0$0$0$0$0
Operating Profit$0$0$0$-2.0M$-17.0M
Net Profit$0$0$0$2.0M$-34.0M
EPS$-0.81$-0.68$-0.01$0.06$-1.64
Op Margin-9450.6%

Balance Sheet (USD)

Metric20192020202120222023
Total Assets$0$0$262.0M$265.0M$32.0M
Total Liabilities$0$0$13.0M$14.0M$71.0M
Cash$0$0$1.0M$0$0
Borrowings$0$0$0$9.0M$12.0M

Cash Flow (USD)

Metric20192020202120222023
Operating Cash Flow$0$0$-1.0M$-1.0M$-15.0M
Investing Cash Flow$0$0$-259.0M$-1.0M$235.0M
Financing Cash Flow$0$0$18.0M$2.0M$-235.0M
Net Cash Flow$0$0$0$-1.0M$-1.0M
Free Cash Flow$0$0$-1.0M$-1.0M$-15.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.50
FCF Yield-265.17%
Quick Ratio0.05
Interest Coverage-378.02
Return 1Y
Return 3Y
Return 5Y

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ENTOEntero Therapeutics, Inc. $2.85 -5.00% -0.82 $13.58M 0.00%
GBNHGreenbrook TMS Inc. $0.12 -40.69% -0.03 $5.52M 0.00%
MDGSXylo Technologies Ltd. $2.36 +10.28% -0.01 $178.86M 0.00%
MODVModivCare Inc. $0.43 +0.00% -0.03 $6.20M 0.00%
NVTAInvitae Corporation $0.02 -35.59% 0.00 $5.44M 0.00%

About Holdco Nuvo Group D.G Ltd. Ordinary Shares

Holdco Nuvo Group D.G Ltd specializes in the innovation, development, and commercialization of medical devices designed for monitoring pregnancies. Its operations span Israel, the United States, and international markets. The company's key offering is the INVU platform, a remote pregnancy monitoring system that provides expectant mothers with a wearable, self-applied wireless sensor. This technology empowers both the mothers and their obstetricians to track maternal and fetal heart rates, along with maternal uterine activity, conveniently from the comfort of home or within a clinical setting, starting from the 32nd week of gestation until the commencement of labor. The INVU platform itself comprises two main elements: a sophisticated wireless sensor band that utilizes multi-modality technology to capture essential physiological signals, and a complementary cloud-based computing environment. This cloud system is responsible for processing and analyzing the collected data, subsequently generating and delivering customized reports on maternal and fetal health metrics. These insights are then conveyed to the mother and her obstetrician through intuitive digital visualization tools. The company has established strategic partnerships with Royal Philips and Charité – Universitätsmedizin Berlin. Founded in 2006, the firm maintains its headquarters in Tel Aviv, Israel, and was formerly known as Nuvo Group Ltd. before changing its name to Holdco Nuvo Group D.G Ltd in May 2024. Notably, on August 22, 2024, Holdco Nuvo Group D.G Ltd initiated Chapter 11 reorganization proceedings by filing a voluntary petition with the U.S. Bankruptcy Court for the District of Delaware.

Holdco Nuvo Group D.G Ltd. Ordinary Shares is headquartered in IL.

Holdco Nuvo Group D.G Ltd. Ordinary Shares (NUVO) stock trades at $0.17 with a market capitalization of $5.65M. The stock is valued at a price-to-earnings (P/E) ratio of -0.10, price-to-book of -0.05, price-to-sales of 32.13. Over the past 52 weeks the stock has ranged between $0.17 and $0.22, and currently trades 22.7% below its 52-week high.

On profitability, Holdco Nuvo Group D.G Ltd. Ordinary Shares generates a return on equity (ROE) of -36.55%, return on capital employed of -1700.00%.

Official website: www.nuvocares.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides